Transforming growth factor-β1 and major depressive disorder with and without attempted suicide: Preliminary study

Psychiatry Research

Volumn 178, Issue 1, 2010, Pages 92-96

  Lee, Hwa Young ^a   Kim, Yong Ku ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Polymorphism

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ALLELE; ARTICLE; ATYPICAL DEPRESSION; CODON; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IN VITRO STUDY; INVOLUTIONAL DEPRESSION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MARKER GENE; PRIORITY JOURNAL; PROTEIN FUNCTION; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; TGF BETA1 GENE;

EID: 80052453711     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2009.03.023     Document Type: Article

References (51)

1. Awad, M.R., El-Gamel, A., Hasleton, P., Turner, D.M., Sinnott, P.J., Hutchinson, I.V., 1998. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 66, 1014-1020.
2. Banks, W.A., 2005. Blood-brain barrier transport of cytokines: a mechanism for neuropathology. Current Pharmaceutical Design 11, 973-984.
3. Barral-Netto, M., Barral, A., Brownell, C.E., Skeiky, Y.A., Ellingsworth, L.R., Twardzik, D.R., Reed, S.G., 1992. Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. Science 257, 545-548.
4. Batuman, O.A., Ferrero, A., Cupp, C., Jimenez, S.A., Khalili, K.,1995. Differential regulation of transforming growth factor beta-1 gene expression by glucocorticoids in human T and glial cells. Journal of Immunology 155, 4397-4405.
5. Berman, A.L., Shepherd, G., Silverman, M.M., 2003. The LSARS-II: Lethality of Suicide Attempt Rating Scale-Updated. Suicide & Life-Threatening Behavior 33, 261-276.
6. Blobe, G.C., Schiemann,W.P., Lodish, H.F., 2000. Role of transforming growth factor beta in human disease. New England Journal of Medicine 342, 1350-1358.
7. Bonaccorso, S., Marino, V., Puzella, A., Pasquini, M., Biondi, M., Artini, M., Almerighi, C., Verkerk, R., Meltzer, H., Maes, M., 2002. Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. Journal of Clinical Psychopharmacology 22, 86-90.
8. Cambien, F., Ricard, S., Troesch, A., Mallet, C., Generenaz, L., Evans, A., Arveiler, D., Luc, G., Ruidavets, J.B., Poirier, O., 1996. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension 28, 881-887.
9. Capuron, L., Ravaud, A., Dantzer, R., 2000. Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. Journal of Clinical Oncology 18, 2143-2151.
10. De Groote, D., Zangerle, P.F., Gevaert, Y., Fassotte, M.F., Beguin, Y., Noizat-Pirenne, F., Pirenne, J., Gathy, R., Lopez, M., Dehart, I., et al.,1992. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 4, 239-248.
11. Dhandapani, K.M., Brann, D.W., 2003. Transforming growth factor-beta: a neuroprotective factor in cerebral ischemia. Cell Biochemistry and Biophysics 39, 13-22.
12. Dunn, A.J., Wang, J., Ando, T., 1999. Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress. Advances in Experimental Medicine and Biology 461, 117-127.
13. Fujii, D., Brissenden, J.E., Derynck, R., Francke, U., 1986. Transforming growth factor beta gene maps to human chromosome 19 long arm and to mouse chromosome 7. Somatic Cell and Molecular Genetics 12, 281-288.
14. Grainger, D.J., Heathcote, K., Chiano, M., Snieder, H., Kemp, P.R., Metcalfe, J.C., Carter, N.D., Spector, T.D., 1999. Genetic control of the circulating concentration of transforming growth factor type beta1. Human Molecular Genetics 8, 93-97.
15. Haack, M., Hinze-Selch, D., Fenzel, T., Kraus, T., Kuhn, M., Schuld, A., Pollmacher, T., 1999. Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. Journal of Psychiatric Research 33, 407-418.
16. Hoffmann, S.C., Stanley, E.M., Cox, E.D., DiMercurio, B.S., Koziol, D.E., Harlan, D.M., Kirk, A.D., Blair, P.J., 2002. Ethnicity greatly influences cytokine gene polymorphism distribution. American Journal of Transplantation 2, 560-567.
17. Horst, H.A., Scheithauer, B.W., Kelly, P.J., Kovach, J.S., 1992. Distribution of transforming growth factor-beta 1 in human astrocytomas. Human Pathology 23, 1284-1288.
18. Hutchinson, I.V., Turner, D.M., Sankaran, D., Awad, M.R., Sinnott, P.J., 1998. Influence of cytokine genotypes on allograft rejection. Transplantation Proceedings 30, 862-863.
19. Kikuchi, K., Tanaka, A., Matsushita, M., Kitazawa, E., Hosoya, N., Kawashima, Y., Selmi, C., Gershwin, M.E., Miyakawa, H., 2007. Genetic polymorphisms of transforming growth factor beta-1 promoter and primary biliary cirrhosis in Japanese patients. Annals of the New York Academy of Sciences 1110, 15-22.
20. Kim, Y.K., Lee, S.W., Kim, S.H., Shim, S.H., Han, S.W., Choi, S.H., Lee, B.H., 2008. Differences in cytokines between non-suicidal patients and suicidal patients in major depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry 32, 356-361.
21. Kim, Y.K., Maes, M., 2003. The role of cytokine network in psychological stress. Acta Neuropsychiatrica 15, 148-155.
22. Kim, Y.K., Suh, I.B., Kim, H., Han, C.S., Lim, C.S., Choi, S.H., Licinio, J., 2002. The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs. Molecular Psychiatry 7, 1107-1114.
23. Kim, Y.K., Na, K.S., Shin, K.H., Jung, H.Y., Choi, S.H., Kim, J.B., 2007. Cytokine imbalance in the pathophysiology of major depressive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry 31, 1044-1053.
24. Kronfol, Z., 2002. Immune dysregulation in major depression: a critical review of existing evidence. International Journal of Neuropsychopharmacology 5, 333-343.
25. Kronfol, Z., Remick, D.G., 2000. Cytokines and the brain: implications for clinical psychiatry. American Journal of Psychiatry 157, 683-694.
26. Krupinski, J., Kumar, P., Kumar, S., Kaluza, J., 1996. Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans. Stroke 27, 852-857.
27. Lee, K.M., Kim, Y.K., 2006. The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder. International Immunopharmacology 6, 1298-1304.
28. Lee, E.B., Kim, J.Y., Lee, Y.J., Abdallah, A., Lympany, P., Song, Y.W., 2004. Transforming growth factor-beta1 polymorphisms in Korean patients with systemic sclerosis. Tissue Antigens 63, 491-495.
29. Leonard, B.E., 2001. Changes in the immune system in depression and dementia: causal or co-incidental effects? International Journal of Developmental Neuroscience 19, 305-312.
30. Letterio, J.J., Roberts, A.B., 1997. TGF-beta: a critical modulator of immune cell function. Clinical Immunology and Immunopathology 84, 244-250.
31. Lu, L.Y., Cheng, H.H., Sung, P.K., Yeh, J.J., Shiue, Y.L., Chen, A., 2004. Single-nucleotide polymorphisms of transforming growth factor-beta1 gene in Taiwanese patients with systemic lupus erythematosus. Journal of Microbiology, Immunology and Infection 37, 145-152.
32. Lympany, P.A., Avila, J.J., Mullighan, C., Marshall, S.,Welsh, K.I., du Bois, R.M., 1998. Rapid genotyping of transforming growth factor beta1 gene polymorphisms in a UK Caucasoid control population using the polymerase chain reaction and sequencespecific primers. Tissue Antigens 52, 573-578.
33. Maes, M., 1999. Major depression and activation of the inflammatory response system. Advances in Experimental Medicine and Biology 461, 25-46.
34. Morganti-Kossmann, M.C., Kossmann, T., Wahl, S.M., 1992. Cytokines and neuropathology. Trends in Pharmacological Sciences 13, 286-291.
35. Myint, A.M., Kim, Y.K., 2003. Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Medical Hypotheses 61, 519-525.
36. Myint, A.M., Leonard, B.E., Steinbusch, H.W., Kim, Y.K., 2005. Th1, Th2, and Th3 cytokine alterations in major depression. Journal of Affective Disorders 88, 167-173.
37. Prud'homme, G.J., Piccirillo, C.A., 2000. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases. Journal of Autoimmunity 14, 23-42.
38. Schiepers, O.J., Wichers, M.C., Maes, M., 2005. Cytokines and major depression. Progress in Neuro-psychopharmacology & Biological Psychiatry 29, 201-217.
39. Schmitt, E., Hoehn, P., Huels, C., Goedert, S., Palm, N., Rude, E., Germann, T., 1994. T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-beta. European Journal of Immunology 24, 793-798.
40. Smith, K., Conroy, R.W., Ehler, B.D., 1984. Lethality of suicide attempt rating scale. Suicide & Life-threatening Behavior 14, 215-242.
41. Strober, W., Kelsall, B., Fuss, I., Marth, T., Ludviksson, B., Ehrhardt, R., Neurath, M., 1997. Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunology Today 18, 61-64.
42. Sugiura, Y., Niimi, T., Sato, S., Yoshinouchi, T., Banno, S., Naniwa, T., Maeda, H., Shimizu, S., Ueda, R., 2002. Transforming growth factor beta1 gene polymorphism in rheumatoid arthritis. Annals of the Rheumatic Diseases 61, 826-828.
43. Suthanthiran, M., Li, B., Song, J.O., Ding, R., Sharma, V.K., Schwartz, J.E., August, P., 2000. Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: a novel mediator of hypertension and/or target organ damage. Proceedings of the National Academy of Sciences of the United States of America 97, 3479-3484.
44. Takebayashi, M., Hisaoka, K., Nishida, A., Tsuchioka, M., Miyoshi, I., Kozuru, T., Hikasa, S., Okamoto, Y., Shinno, H., Morinobu, S., Yamawaki, S., 2006. Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorders. International Journal of Neuropsychopharmacology 9, 607-612.
45. Wahl, S.M., Allen, J.B., McCartney-Francis, N., Morganti-Kossmann, M.C., Kossmann, T., Ellingsworth, L., Mai, U.E., Mergenhagen, S.E., Orenstein, J.M., 1991. Macrophageand astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. Journal of Experimental Medicine 173, 981-991.
46. Watkins, L.R., Maier, S.F., Goehler, L.E., 1995. Cytokine-to-brain communication: a review & analysis of alternative mechanisms. Life Sciences 57, 1011-1026.
47. Weisman, A.D.,Worden, J.W., 1972. Risk-rescue rating in suicide assessment. Archives of General Psychiatry 26, 553-560.
48. Wyss-Coray, T., Masliah, E., Mallory, M., McConlogue, L., Johnson-Wood, K., Lin, C., Mucke, L., 1997. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease. Nature 389, 603-606.
49. Yamada, Y., Miyauchi, A., Goto, J., Takagi, Y., Okuizumi, H., Kanematsu, M., Hase, M., Takai, H., Harada, A., Ikeda, K., 1998. Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. Journal of Bone and Mineral Research 13, 1569-1576.
50. Yokota, M., Ichihara, S., Lin, T.L., Nakashima, N., Yamada, Y., 2000. Association of a T29-N C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 101, 2783-2787.
51. Zhang, L., Yi, H., Xia, X.P., Zhao, Y., 2006. Transforming growth factor-beta: an important role in CD4+CD25+ regulatory T cells and immune tolerance. Autoimmunity 39, 269-276.